HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup

STAT+: 931 days. The drug approval scandal hiding in plain sight

Two years, six months, and 18 days have elapsed since Northwest Biotherapeutics submitted its brain cancer treatment for regulatory approval.

By STAT News · Jul 9, 2026 · via STAT News
STAT+: 931 days. The drug approval scandal hiding in plain sight

Image: STAT News

This is an aggregated industry headline. Read the full story at STAT News

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Allergan Aesthetics on Tuesday welcomed Girls Inc. participants to a panel and tour at its Allergan Medical In…
Jul 9, 2026
The WeekFierceBiotech ↗
The FDA has paused a controversial policy of releasing letters describing its rationale for rejecting drugs, F…
Jul 9, 2026
Dexcom’s OTC CGM raises pediatric, public health questions
The WeekBriefing
The newly approved Dexcom Stelo continuous glucose monitor opens access beyond diabetes management, prompting …
Jul 9, 2026